s
EpiVax Strengthens Technology Leadership Amid Immunoinformatics Advancements
27-02-2025, 15:08
PROVIDENCE, R.I., Feb. 27, 2025 /PRNewswire/ — EpiVax, Inc. proudly announces the appointment of Guilhem Richard as Chief Technology Officer. Dr. Richard joined EpiVax’s immunoinformatics team in 2014 and spearheaded the development of a new computational platform for developing personalized, neoantigen-based cancer vaccines: Ancer®. He subsequently oversaw translational work of this technology at EpiVax’s subsidiary […] L'articolo EpiVax Strengthens Technology Leadership Amid Immunoinformatics Advancements proviene da La Ragione.
CONTINUA A LEGGERE
26
0
0